A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL

  检 索： 期刊名称 ISSN         高级检索

期刊名称：IN VIVO ISSN： 0258-851X 出版频率： Bimonthly 出版社： INT INST ANTICANCER RESEARCH, EDITORIAL OFFICE, 1ST KM KAPANDRITIOU-KALAMOU RDKAPANDRITI, PO BOX 22ATHENS, GREECE, 19014 期刊网址： http://www.iiar-anticancer.org/invivo/invivo_index.htm 影响因子： 0.99(2008) 主题范畴： MEDICINE, RESEARCH & EXPERIMENTAL 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal IN VIVO is a multidisciplinary journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frame of comparative physiology and pathology. A special focus of the journal is the publication of works on: (a) Experimental development and application of new diagnostic procedures; (b) Pharmacological and toxicological evaluation of new drugs and drug combinations; (c) Development and characterization of models of biomedical research. IN VIVO is the official journal of the International Society for the Study of Comparative Oncology, Inc. (ISSCO) (President : Prof. H.E. Kaiser, 433 South West Drive, Silver Spring, MD 20901, USA), and Deutsche Gesellschaft fur Vergleichende Onkologie (Vergleichende Krebserforschung und Krebsbekaempfung) e.V. (German Society for Comparative Oncology, Inc.) (President : H.E. Kaiser). IN VIVO supports (a) the establishment and the activities of the INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH and (b) the organization of the INTERNATIONAL CONFERENCES OF ANTICANCER RESEARCH. IN VIVO is published bimonthly. Each annual volume contains six issues and index. Articles in IN VIVO are regulary indexed in bibliographic services, including Index Medicus, MEDLINE, Biological Abstracts, BIOSIS, Chemical Abstracts, Excerpta Medica, CANCER-LIT Database, University of Sheffield Biomedical Information Service (SUBIS), Current Clinical Cancer, AIDS Abstracts, Progress in Paliative Care, Update-Research Information Systems Inc., Inpharma-Reactions Datastar, BRS), Reference Update (I.S.I.), Research Alert (I.S.I.), BioBase, MedBase, Investigational Drugs Database. Instructions to Authors Manuscripts Two types of papers may be submitted: (i) Papers containing completed original work, and (ii) review articles concerning fields of recognizable progress. Papers should be written in clear, concise English. Spelling should follow that given in the "Shorter Oxford English Dictionary". Ideally, manuscripts should not exceed fourteen (14) pages (approx. 250 words per double-spaced typed page) corresponding to four (4) printed pages. Papers exceeding four printed pages will be subject to excess page charges. All manuscripts should be divided into the following sections : (a) First page including the title of the presented work, full names and full postal addresses of all Authors, name of the Author to whom proofs are to be sent, key words, and an abbreviated running title; (b) Abstracts not exceeding 150 words, organized according to the following headings: Background-Materials and Methods-Results-Conclusions; (c) Introduction; (d) Materials and Methods, or Patients and Methods; (e) Results; (f) Discussion; (g) Acknowledgements, and (h) References. All pages must be numbered consecutively. Footnotes should be avoided. Review articles may follow a different style according to the subject matter and the Author's opinion. Review articles should not exceed 35 pages (approximately 250 words per double-spaced typed page) including all tables, figures, and references. Figures   All figures (whether photographs or graphs) should be clear, high contrast, glossy prints of the size they are to appear in the journal : 8.00 cm (3.15 in.) wide for a single column; 17.00cm (6.70 in.) for a double column; maximum height: 20.00 cm (7.87 in.). Graphs must be submitted as photographs made from drawings and must not require any artwork, typesetting, or size modifications. Symbols, numbering, and lettering should be clearly legible. The number and top of each figure must be indicated on the reverse side. Original karyotypes and photographs should be provided wherever possible, and not photographic copies. A charge will be made for a colour plate. Tables Each table should be submitted on a separate page, typed double-spaced. Tables should be numbered with Roman numerals and should include a short title. Nomenclature and Abbreviations Nomenclature should follow that given in "Chemical Abstracts". Standard abbreviations will be preferable. If a new abbreviation is used, it must be defined at its first usage. References Citations for the reference sections of submitted works should follow the standard form of "Index Medicus" and must be numbered consecutively. In the text, references should be cited by number. Examples : 1 Sumner AT : The nature of chromosome bands and their significance for cancer research. Anticancer Res 1: 205-216, 1981. 2 McGuire WL and Chamness GC: Studies on the oestrogen receptor in breast cancer. In: Receptors for reproductive hormones (O' Malley BW and Chamness GC, eds). New York, Plenum Publ Corp, 1973, pp 113-136. Submission of Manuscripts An original and two copies of the manuscript (including all photographs and graphs) should be sent to Dr.J.G. Delinassios, Managing Editor, IN VIVO, Editorial Office, International Institute of Anticancer Research, 1st km Kapandritiou-Kalamou Rd., Kapandriti, P.O.B. 22 Attiki 19014, Greece. A floppy disc may also be submitted indicating the computer-processing program. Only the original copy of the submitted manuscript will be returned to Authors upon rejection. Galley Proofs Unless otherwise indicated galley proofs will be sent to the first-named Author of the submission. Reprints Reprints may be ordered after the acceptance of the paper. Editorial Board     N.J. AGNANTIS, Department of Pathology, University of Ioannina, Ioannina, Greece D. ANDERSON, Genetic Toxicology and Cell Biology Dept., British Industrial Biological Research Association, Surrey, UK V. BARAK, Department of Oncology, Hadassah University Hospital, Jerusalem, Israel R.J.B. BASSLEER, Department of Histology, Universit?de Li鑗e, Belgium Y. BECKER, Department of Molecular Virology, Hebrew University of Jerusalem, Israel K. BEIER, Abt. Histologie, Anatomisches Institut der Universitat Bael, Basel, Switzerland S. BEN-EFRAIM, Department of Human Microbiology, Sackler School of Medicine,Tel-Aviv University Israel J. BEUTH, Institut zur Wissenschaftlichen Evaluation Naturheilkundlicher Verfahren, Univ. zu K鰈n, Germany R. BJERKVIG, Dept. of Anatomy and Cell Biology, University of Bergen, Norway B. BODEY, Department of Pathology, School of Medicine, University of Southern California, Los Angeles, CA, USA K. W. BRUNSON, Fort Worth, TX, USA  P. CHANDRA, Abt. fur Molekularbiologie, Klinikum Wolfgang Goethe-Universit鋞, Frankfurt am Main, Germany J.-G. CHUNG, Department of Medicine, China Medical College, Taichung, Taiwan L.A. COHEN, American Health Foundation, Valhalla, NY, USA A.I. CONSTANTINOU, Dept. of Surgical Oncology, College of Medicine, University of Illinois, Chicago, IL, USA J.G. CORY, Dept. of Biochemistry & Molecular Biology, Brody School of Medicine, East Carolina Univ., Greenville, NC, USA T. DALIANIS, Karolinska Institute, Dept. of Oncology-Pathology, Cancer Ctr Karolinska, Stockholm, Sweden I. DAMJANOV, Department of Pathology, University of Kansas School of Medicine, Kansas City, KS, USA G. DELICONSTANTINOS, Department of Physiology, University of Athens Medical School, Athens, Greece D.T. DENHARDT, Department of Biological Sciences, Rutgers University, Piscataway, NJ, USA  W. DEN OTTER, Department of Pathology, University of Utrecht, The Netherlands L. DE RIDDER, Sect. Histologie, Universiteit Gent, Belgium E.P. DIAMANDIS, Dept. of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ont., Canada J.F. DOR?/B>, Centre L閛n B閞ard, Lyon France E. EIGENBRODT, Institute for Biochemistry & Endocrinology, Justus-Liebig-Univ. of Giessen, Giessen, Germany I. EMBER, Institute of Preventive Medicine,University Medical School, P閏s, Hungary W. ENGSTR諱, Dept. of Virology, Swedish Univ. of Agricultural Sciences, Uppsala, Sweden M. ESKELINEN, Department of Surgery, University of Kuopio, Finland J.A. FERNANDEZ-POL, Laboratory of Molecular Oncology, VA Medical Center, St.Louis, Mo, USA S. FERRONE, Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY, USA P.B. FISHER, Department of Microbiology, College of Physicians and Surgeons, Columbia University, New York, NY, USA I. FREITAS, Dip. di Biologia Animale, University of Pavia, Italy R.E. FRIEDRICH, Dept. of Oral & Maxillofacial Surgery, Eppendorf Univ. Hospital, Univ. of Hamburg, Hamburg, Germany R. GANAPATHI, Taussing Cancer Center, Cleveland Clinic Foundation, Cleveland, OH, USA D.H. GILDEN, Dept. of Neurology, University of Colorado School of Medicine, Denver, CO, USA G. GITSCH, Dept. of Gynecology and Obstetrics, Univ. of Vienna, Austria J.S. GREENBERGER, Department of Radiation Oncology, School of Medicine, University of Pittsburgh, PA, USA J.W. GREINER, National Cancer Institute, NIH, Bethesda, MD, USA C.J. GRUBBS, Department of Nutrition Sciences, University of Alabama, Birmingham, AL, USA F. GUADAGNI, Regina Elena Cancer Institute, Rome, Italy K.A. HAHN, Dept. of Comparative Medicine, College of Veterinary Medicine, Univ. of Tennessee, Knoxville, TN, USA F. HALBERG, Chronobiology Laboratories, University of Minnesota, Minneapolis, MN, USA T. HAMAOKA, Osaka, Japan R.R. HARDY, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA J. HAU, Department of Physiology, Div. of Comparative Medicine, Uppsala University, Uppsala, Sweden G.H. HEPPNER, Department of Immunology, Michigan Cancer Foundation, Detroit, MI, USA H.R. HUBBELL, Department of Neoplastic Diseases, Hahnermann University, Philadelphia, PA, USA S.A. IMAM, Cancer Research Laboratory, University of Southern California, Los Angeles, CA, USA C.G. IOANNIDES, Department of Gynecology, M.D. Anderson Cancer Center, Houston, TX, USA A. ITO, Dept. of Oncology, Res. Inst. for Nuclear Medicine and Biology, Hiroshima Univ., Japan J.R. IZBICKI, Chirurgische Universit鋞sklinik, Universit鋞skrankenhaus, Hamburg, Germany K.S. JEONG, Department of Pathology, College Vet. Medicine, Kyungpook National University, Daegu, S. Korea H.E. KAISER, International Society for the study of Comp. Oncology, Baltimore, MD, USA J. KELLEN, Department of Clinical Biochemistry, University of Toronto, Ontario, Canada M. KOUTSILIERIS, Department of Experimental Physiology, Medical Sch. Univ. of Athens, Athens, Greece G.R.F. KRUEGER, Immunopathology Section, Institute of Pathology, University of K鰈n, Germany T. KUBOTA, Dept. of Surgery, School of Medicine, Keio University, Tokyo, Japan S.A. LAMPRECHT, Gastroenterology Laboratory, Ben Gurion University of the Negev, Beer Sheva, Israel G. LANDBERG, Div. of Pathology, Dept. of Laboratory Medicine, Lund University, Sweden J. LEROY, IRCAD, University of Strasbourg, France B. L蒠LAND-JONES, Department of Oncology, McGill University, Montreal, Quebec, Canada P. MADARNAS, Department of Pathology, University of Sherbrooke, Qu閎ec, Canada H. MAEDA, Department of Microbiology, Kumamoto University, Japan M. MAREEL, Laboratory of Experimental Cancerology, State University, Ghent, Belgium J. MATTERN, Institute of Experimental Pathology, German Cancer Research Center, Heidelberg, Germany D. P. MIKHAILIDIS, Department of Chemical Pathology and Human Metabolism, The Royal Free Hospital, London, UK H. C. MORSE III, Lab. of Immunopathology, National Institutes of Health, Bethesda, MD, USA N. MOTOHASHI, Dept. of Medical Chemistry, Meiji College of Pharmacy, Tokyo, Japan H. NAGASAWA, Experimental Animal Research Laboratory, Meiji University, Kanagawa, Japan R. M. NAGLER, Haifa, Israel R. NARAYANAN, Dept. of Biological Sciences, Florida Atlantic Univ., Boca Raton, FL,USA K. NILSSON, Tumor Biology Laboratory, Department of Pathology, University Hospital, Uppsala, Sweden K. R. NORUM, Institute for Nutrition Research, Universitetet i Oslo, Norway R. F. NOVAK, Institute of Chemical Toxicology, Wayne State University, Detroit, MI, USA J. O'KELLY, Div. of Hematology/Oncology, Cedars Sinai Med. Ctr., UCLA Sch. of Medicine, Los Angeles, CA, USA M. PAG?/B>, Departement de Biochimie, Facult?de M閐ecine, Universit?Laval, Qu閎ec, Canada P. PANTAZIS, Dept. of Biology, University of Miami, Coral Gables, FL, USA M.-F. POUPON, Institut Curie, Section de Recherch? Paris, France M. PSALLIDOPOULOS, Institute for Biomedical Research and Biotechnology, Athens, Greece C.A. RUBIO, Department of Pathology, Karolinska Institutet, Stockholm, Sweden G.R. RUTTEMAN, Faculty of Veterinary Medicine, University of Utrecht, The Netherlands H. SAKAGAMI, Department of Dental Pharmacology, Meikai University School of Dentistry, Saitama, Japan G. SAVA, Instituto di Farmacologia e Farmacognosia, Universit?di Trieste, Italy K.J. SCANLON, City of Hope National Medical Center, Duarte, CA, USA D. SCHIFFER, Dept. of Neurosciences, University of Torino, Torino, Italy L.D. SHULTZ, The Jackson Laboratory, Bar Harbor, ME, USA G. SICA, Instituto di Istologia ed Embriologia, Univ. Cattolica del S. Cuore, Roma, Italy R.M. SNAPKA, Dept. of Radiology, The Ohio State University, Columbus, OH, USA G.-I. SOMA, Biotechnology Research Center, Kawasaki, Kanagawa, Japan T.A. SPRINGER, Department of Pathology, Harvard Medical School, Boston, MA, USA K.TAKAGI, Kennan Takagi Clinic, Kumamoto, Japan T. TAKAHASHI, Aichi Cancer Center Research Institute, Nagoya, Japan N. TANAKA, Research Institute, Daiichi Seiyaku Co., Tokyo, Japan H. TAPIERO, Department of Cellular and Molecular Pharmacology, I.C.I.G., Villejuif, France K.D. TEW, Fox Chase Cancer Center, Philadelphia, PA, USA T. TOGE, Res. Inst. for Nuclear Medicine and Biology, Hiroshima University, Japan G.C. TORRE, Department of Obstetrics and Gynecology, Albenga (SV), Italy B. TRIBUKAIT, Department of Medical Radiobiology, Karolinska Institute, Stockholm, Sweden C. TROP?/B>, Radiumhospitalet, Oslo, Norway P. TSONIS, Dept. of Biology, University of Dayton, OH, USA T. TSURUO, Institute of Molecular and Cellular Biosciences, University of Tokyo, Japan J. VADGAMA, Dept. of Internal Medicine, UCLA School of Medicine, Los Angeles, CA, USA A. VECCHIONE, Universita degli Studi di Roma "La Sapienza", Rome, Italy N. WATANABE, Dept. of Clinical Laboratory Medicine, Sapporo Medical University, Sapporo, Japan W. WEBER, Clinical Cancer Etiology Unit, Basel, Switzerland L.M. WEINER, Fox Chase Cancer Center, Philadelphia, PA, USA J.A. WERNER, Dept. of Otolaryngology, Head & Neck Surgery, Philipps Univ. Marburg, Germany H. YAMAUE, Second Dept. of Surgery, Wakayama Medical University, Wakayama, Japan H. YOSHIDA, Department of Pathology, Kagoshima University, Kagoshima, Japan O. YUGE, Dept. of Anesthesiology and Clinical Medicine, Hiroshima University, Japan